Lv31
290 积分 2024-05-19 加入
Tislelizumab plus chemotherapy versus placebo plus chemotherapy as first line treatment for advanced gastric or gastro-oesophageal junction adenocarcinoma: RATIONALE-305 randomised, double blind, phase 3 trial
4小时前
已完结
Ramucirumab plus paclitaxel as switch maintenance versus continuation of first-line oxaliplatin-based chemotherapy in patients with advanced HER2-negative gastric or gastro-oesophageal junction cancer (ARMANI): a randomised, open-label, multicentre, phase 3 trial
4小时前
已完结
First-line cadonilimab plus chemotherapy in HER2-negative advanced gastric or gastroesophageal junction adenocarcinoma: a randomized, double-blind, phase 3 trial
4小时前
已完结
Sepsis and Septic Shock
1个月前
已完结
Sepsis and septic shock
1个月前
已关闭
Sepsis and septic shock
1个月前
已完结
Prediction of traumatic hemorrhagic shock using a Multi-scale exogenous variable model (MS-TimeXer-MoE)
2个月前
已完结
Blood transfusion strategies for major bleeding in trauma
2个月前
已完结
Fresh Whole Blood Transfusion: A Controversial Military Practice
3个月前
已完结
“Target Trial Emulation” for Observational Studies — Potential and Pitfalls
5个月前
已完结
皖公网安备34019202002308
